Wockhardt gets warning letter from USFDA: Report

04 Jan 2017 Evaluate

The US Food and Drug Administration (USFDA) has reportedly issued a warning letter to Wockhardt's Ankleshwar plant for data integrity issues, destruction of records and other violation of good manufacturing practices. Three of the company's plants, including the one at Ankleshwar, are under an import alert.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1350.35 -27.05 (-1.96%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×